Graphene quantum dot based charge-reversal nanomaterial for nucleus-targeted drug delivery and efficiency controllable photodynamic therapy.


Journal

Journal of biophotonics
ISSN: 1864-0648
Titre abrégé: J Biophotonics
Pays: Germany
ID NLM: 101318567

Informations de publication

Date de publication:
06 2019
Historique:
received: 23 09 2018
revised: 28 01 2019
accepted: 29 01 2019
pubmed: 1 2 2019
medline: 15 7 2020
entrez: 1 2 2019
Statut: ppublish

Résumé

Graphene quantum dots (GQDs), the new zero-dimensional carbon nanomaterial, have been demonstrated as a promising material for biomedical applications due to its good biocompatibility and low toxicity. However, the integration of multiple therapeutic approaches into a nanosized platform based on the GQD has not been explored yet to our best knowledge. In this report, we regulate the generation of reactive oxygen species (ROS) when using the GQD as a photosensitizer by varying the doping amount of nitrogen atoms to achieve efficiency controllable photodynamic therapy. On the other hand, charge-reversal (3-Aminopropyl) triethoxysilane (APTES) was used to conjugate on the surface of GQD for nucleus targeting drug delivery for the first time. The treatment outcome of produced ROS and nucleus-targeting drug delivery was investigated by fluorescence imaging. The results demonstrated that the N-GQD-DOX-APTES in dual roles as a drug carrier and photosensitizer could achieve nucleus-targeting delivery and strong ROS production simultaneously. This approach provides a promising strategy for the development of multifunctional therapy in one nano platform for biomedical applications.

Identifiants

pubmed: 30701677
doi: 10.1002/jbio.201800367
doi:

Substances chimiques

Drug Carriers 0
Propylamines 0
Silanes 0
Graphite 7782-42-5
Doxorubicin 80168379AG
amino-propyl-triethoxysilane L8S6UBW552

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e201800367

Subventions

Organisme : Biomedical Research Council, Singapore
ID : H17/01/a0/008
Pays : International
Organisme : Biomedical Research Council, Singapore
ID : H17/01/a0/0F9
Pays : International
Organisme : Ministry of Education in Singapore
ID : MOE2015-T2-2-112
Pays : International
Organisme : Ministry of Education in Singapore
ID : MOE2017-T2-2-057
Pays : International
Organisme : Nanyang Technological University (SG)
ID : NAM/15004
Pays : International

Informations de copyright

© 2019 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Auteurs

Jian Ju (J)

School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore.
Department of Chemistry, Oakland University, Rochester, Michigan.

Sagar Regmi (S)

School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore.

Afu Fu (A)

School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore.

Sierin Lim (S)

School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore.

Quan Liu (Q)

School of Chemical and Biomedical Engineering, Nanyang Technological University, Singapore.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH